Letter to Editor Regarding Narula et al, IBD 2017, Budenoside Use Is a Key Quality Marker in the Management of IBD.

Inflamm Bowel Dis

*Department Gastroenterology, St George's University of London, St George's University Hospitals NHS Foundation Trust, London, United Kingdom †Department of Primary Care and Public Health, Charing Cross Campus, Imperial College London, London, United Kingdom.

Published: August 2017

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000001184DOI Listing

Publication Analysis

Top Keywords

letter editor
4
editor narula
4
narula ibd
4
ibd 2017
4
2017 budenoside
4
budenoside key
4
key quality
4
quality marker
4
marker management
4
management ibd
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!